Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 1,114 shares at $107.22 ($119K) on 2023-09-08, disclosed to the SEC on 2023-09-11.
Scheduled sale ($119k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.22 | 557 | $60K | 50.0% |
| 2 | $107.22 | 557 | $60K | 50.0% |
| Total | $107.22 avg | 1,114 | $119K | 100% |
| Filing → |
| MRNA | SELL | 2026-03-03 | $726K | — | Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |